Off-topic for aiqbench

This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.

CSPC Deepens Strategic Partnership with Boehringer Ingelheim in Deal Worth Up to $7 Billion

36KrNovember 4, 20261 min read

36Kr learned that on November 4, CSPC Pharmaceutical Group announced it has signed strategic option and licensing agreements with Boehringer Ingelheim (BI), covering six innovative drug preclinical projects, with a total deal value of up to $7 billion. This is the second collaboration between the two companies in the oncology field.

Read the full article at 36Kr

Read at 36Kr ↗Ask about this article